Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Spinout Syntopix announces new funding deal

28.10.2004


University of Leeds life sciences company Syntopix Ltd has secured further capital of just under £180,000 through a consortium of regional investors.

Formed in 2003, Syntopix is based on the leading research of husband and wife team Drs Jon Cove and Anne Eady, both microbiologists in the University’s Skin Research Centre. Their work focuses on developing novel therapeutics for dermatological diseases, including acne and Staphylococcus aureus infections such as the ‘superbug’ MRSA.

The deal, announced this week, sees investment from a consortium comprising: Techtran Group Ltd, regional venture capital funds the White Rose Technology Seedcorn Fund and the Viking Fund, and business angels Dr Gwyn Humphreys and Dr Rod Adams.



Dr Humphreys has been appointed as the company’s new chairman and Dr Adams joins Syntopix as a non-executive director. Both have successful track records in growing businesses in the pharmaceutical industry. Dr Humphreys was joint founder / CEO of Bradford Particle Design, sold to Inhale Therapeutics in 2001 for $200m and Dr Adams was formerly CEO of Medical Solutions plc and local dermatology company Adams Healthcare. Dr Alex Stevenson has joined the company as Chief Executive Officer.

Syntopix was spun out by Techtran Group, the commercialisation partner of the University of Leeds, and the science underpinning the company was initially funded with £500,000 from the Wellcome Trust. The company’s approach is to generate new therapeutic products for target diseases by identifying novel combinations of compounds which together deliver new therapeutic benefits. Since the majority of the compounds used already have well-documented pharmacology and toxicity profiles and are already established as safe for human use, the development cycle of new products can be substantially reduced, saving both time and money. The company is rapidly developing a pipeline of its own drug candidates, and expects to commence clinical trials of its lead candidates in the next two to three years.

In addition the company offers contract testing and expert consultancy in pre-clinical and clinical drug development. A number of contracts with partners in the dermatology arena are already in place. The new funding strengthens the management structure, increases the research team to six and will accelerate the development of anti-acne products.

Syntopix CEO Dr Alex Stevenson said: “We are delighted to have received the backing of such a broad range of regional investors and look forward to bringing the results of our research to the clinic.”

The White Rose Technology Seedcorn Fund has to date invested in nineteen spinout companies from the Universities of Leeds, Sheffield and York. Investment Manager, Dr Susan Hill, said: “We were attracted to Syntopix’ considerable expertise in the field of skin diseases, which includes a number of significant markets, and the company’s approach to product development. We look forward to working with the team to deliver on its exciting potential.”

The investment is the first for the Viking Fund, which was established in June to provide seed capital for technology-based early stage companies in the Yorkshire and Humber region. Viking Fund managing director Andrew Burton said: “Syntopix is fairly typical of early-stage, technology businesses in which Viking Fund is looking to invest. It has high quality science, a simple commercial model, experienced people and ready matching investment.”

Dr Alex Stevenson | alfa
Further information:
http://www.syntopix.com

More articles from Life Sciences:

nachricht The dense vessel network regulates formation of thrombocytes in the bone marrow
25.07.2017 | Rudolf-Virchow-Zentrum für Experimentelle Biomedizin der Universität Würzburg

nachricht Fungi that evolved to eat wood offer new biomass conversion tool
25.07.2017 | University of Massachusetts at Amherst

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Carbon Nanotubes Turn Electrical Current into Light-emitting Quasi-particles

Strong light-matter coupling in these semiconducting tubes may hold the key to electrically pumped lasers

Light-matter quasi-particles can be generated electrically in semiconducting carbon nanotubes. Material scientists and physicists from Heidelberg University...

Im Focus: Flexible proximity sensor creates smart surfaces

Fraunhofer IPA has developed a proximity sensor made from silicone and carbon nanotubes (CNT) which detects objects and determines their position. The materials and printing process used mean that the sensor is extremely flexible, economical and can be used for large surfaces. Industry and research partners can use and further develop this innovation straight away.

At first glance, the proximity sensor appears to be nothing special: a thin, elastic layer of silicone onto which black square surfaces are printed, but these...

Im Focus: 3-D scanning with water

3-D shape acquisition using water displacement as the shape sensor for the reconstruction of complex objects

A global team of computer scientists and engineers have developed an innovative technique that more completely reconstructs challenging 3D objects. An ancient...

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA mission surfs through waves in space to understand space weather

25.07.2017 | Physics and Astronomy

Strength of tectonic plates may explain shape of the Tibetan Plateau, study finds

25.07.2017 | Earth Sciences

The dense vessel network regulates formation of thrombocytes in the bone marrow

25.07.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>